Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Operating Margin (2020 - 2022)

Historic Operating Margin for Therapeutics (RAPT) over the last 3 years, with Q2 2022 value amounting to 2134.2%.

  • Therapeutics' Operating Margin fell 2836800.0% to 2134.2% in Q2 2022 from the same period last year, while for Mar 2023 it was 10900.68%, marking a year-over-year decrease of 86288600.0%. This contributed to the annual value of 5618.53% for FY2022, which is 38034500.0% down from last year.
  • Per Therapeutics' latest filing, its Operating Margin stood at 2134.2% for Q2 2022, which was down 2836800.0% from 3241.34% recorded in Q1 2022.
  • In the past 5 years, Therapeutics' Operating Margin ranged from a high of 954.25% in Q3 2020 and a low of 3241.34% during Q1 2022
  • Over the past 3 years, Therapeutics' median Operating Margin value was 1622.42% (recorded in 2021), while the average stood at 1721.86%.
  • As far as peak fluctuations go, Therapeutics' Operating Margin skyrocketed by 390900bps in 2021, and later tumbled by -18861000bps in 2022.
  • Quarter analysis of 3 years shows Therapeutics' Operating Margin stood at 1004.99% in 2020, then crashed by -137bps to 2385.45% in 2021, then increased by 11bps to 2134.2% in 2022.
  • Its Operating Margin was 2134.2% in Q2 2022, compared to 3241.34% in Q1 2022 and 2385.45% in Q4 2021.